LIVIVO - Search results -

Search results

Result 1 - 10 of total 15

Search options

Article ; Online: Cutaneous Pharmacokinetics of Topically Applied Novel Dermatological Formulations.

Patel, Meenakshi / Patel, Ashwini / Desai, Jagruti / Patel, Swayamprakash

2024 Volume 25, Issue 3, Page(s) 46

Abstract: Novel formulations are developed for dermatological applications to address a wide range of patient needs and therapeutic challenges. By pushing the limits of pharmaceutical technology, these formulations strive to provide safer, more effective, and ... ...

Abstract	Novel formulations are developed for dermatological applications to address a wide range of patient needs and therapeutic challenges. By pushing the limits of pharmaceutical technology, these formulations strive to provide safer, more effective, and patient-friendly solutions for dermatological concerns, ultimately improving the overall quality of dermatological care. The article explores the different types of novel dermatological formulations, including nanocarriers, transdermal patches, microsponges, and microneedles, and the techniques involved in the cutaneous pharmacokinetics of these innovative formulations. Furthermore, the significance of knowing cutaneous pharmacokinetics and the difficulties faced during pharmacokinetic assessment have been emphasized. The article examines all the methods employed for the pharmacokinetic evaluation of novel dermatological formulations. In addition to a concise overview of earlier techniques, discussions on novel methodologies, including tape stripping, in vitro permeation testing, cutaneous microdialysis, confocal Raman microscopy, and matrix-assisted laser desorption/ionization mass spectrometry have been conducted. Emerging technologies like the use of microfluidic devices for skin absorption studies and computational models for predicting drug pharmacokinetics have also been discussed. This article serves as a valuable resource for researchers, scientists, and pharmaceutical professionals determined to enhance the development and understanding of novel dermatological drug products and the complex dynamics of cutaneous pharmacokinetics.
MeSH term(s)	Humans ; Skin/metabolism ; Administration, Cutaneous ; Skin Absorption ; Technology, Pharmaceutical ; Microdialysis/methods
Language	English
Publishing date	2024-02-27
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	2052070-0
ISSN	1530-9932 ; 1530-9932
ISSN (online)	1530-9932
ISSN	1530-9932
DOI	10.1208/s12249-024-02763-4
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Structural Insights of PD-1/PD-L1 Axis: An In silico Approach.

Rohit, Shishir / Patel, Mehul / Jagtap, Yogesh / Shah, Umang / Patel, Ashish / Patel, Swayamprakash / Solanki, Nilay

Current protein & peptide science

2024

Abstract: Background: Interaction of PD-1 protein (present on immune T-cell) with its ligand PD-L1 (over-expressed on cancerous cell) makes the cancerous cell survive and thrive. The association of PD-1/PD-L1 represents a classical protein-protein interaction ( ... ...

Abstract	Background: Interaction of PD-1 protein (present on immune T-cell) with its ligand PD-L1 (over-expressed on cancerous cell) makes the cancerous cell survive and thrive. The association of PD-1/PD-L1 represents a classical protein-protein interaction (PPI), where receptor and ligand binding through a large flat surface. Blocking the PD-1/PDL-1 complex formation can restore the normal immune mechanism, thereby destroying cancerous cells. However, the PD-1/PDL1 interactions are only partially characterized. Objective: We aim to comprehend the time-dependent behavior of PD-1 upon its binding with PD-L1. Method: The current work focuses on a molecular dynamics simulation (MDs) simulation study of apo and ligand bound PD-1. Results: Our simulation reveals the flexible nature of the PD-1, both in apo and bound form. Moreover, the current study also differentiates the type of strong and weak interactions which could be targeted to overcome the complex formation. Conclusion: The current article could provide a valuable structural insight about the target protein (PD-1) and its ligand (PD-L1) which could open new opportunities in developing small molecule inhibitors (SMIs) targeting either PD-1 or PD-L1.
Language	English
Publishing date	2024-05-03
Publishing country	United Arab Emirates
Document type	Journal Article
ZDB-ID	2045662-1
ISSN	1875-5550 ; 1389-2037
ISSN (online)	1875-5550
ISSN	1389-2037
DOI	10.2174/0113892037297012240408063250
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5884: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: DE-INTERACT: A machine-learning-based predictive tool for the drug-excipient interaction study during product development-Validation through paracetamol and vanillin as a case study.

Patel, Swayamprakash / Patel, Mehul / Kulkarni, Mangesh / Patel, Mruduka S

International journal of pharmaceutics

2023 Volume 637, Page(s) 122839

Abstract: The compatibility of drugs with excipients plays a crucial role in the prospective stability of pharmaceutical formulations. Apart from real-time stability studies, conventional analytical tools like DSC, FTIR, NMR, and chromatography help identify the ... ...

Abstract	The compatibility of drugs with excipients plays a crucial role in the prospective stability of pharmaceutical formulations. Apart from real-time stability studies, conventional analytical tools like DSC, FTIR, NMR, and chromatography help identify the possibilities of drug-excipient interactions. Machine learning can assist in developing a predictive tool for drug-excipient incompatibility. In the present work, PubChem Fingerprint is employed as the descriptor of compounds that thoroughly represents the drug's and excipient's chemistry. The 881-bit binary fingerprints of each drug and excipient make 1762 inputs, and one categorical output makes an instance in the dataset. A dataset of more than 3500 instances of drugs and excipients is carefully selected from peer-reviewed research papers. Rigorous training of the Artificial Neural Network (ANN) model was performed with maximum validation accuracy, minimum validation loss, and maximum validation precision as the checkpoints. The machine learning model (DE-Interact) was trained, achieving training and validation accuracies of 0.9930 and 0.9161, respectively. The performance of the DE-Interact model was evaluated by confirming three incompatible predictions by conventional analytical tools. Paracetamol with vanillin, paracetamol with methylparaben, and brinzolamide with polyethyleneglycol are these instances which are predicted as incompatible by the DE-Interact. DSC, FTIR, HPTLC, and HPLC analysis confirm the prediction. The present work offers a reliable DE-Interact tool for quick referencing while selecting excipients in formulation design.
MeSH term(s)	Excipients/chemistry ; Acetaminophen ; Prospective Studies ; Drug Stability ; Machine Learning
Chemical Substances	Excipients ; Acetaminophen (362O9ITL9D) ; vanillin (CHI530446X)
Language	English
Publishing date	2023-03-15
Publishing country	Netherlands
Document type	Journal Article
ZDB-ID	428962-6
ISSN	1873-3476 ; 0378-5173
ISSN (online)	1873-3476
ISSN	0378-5173
DOI	10.1016/j.ijpharm.2023.122839
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1409: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Emerging green synthetic routes for thiazole and its derivatives: Current perspectives.

Patel, Maitri / Bambharoliya, Tushar / Shah, Drashti / Patel, Krina / Patel, Mehul / Shah, Umang / Patel, Swayamprakash / Mahavar, Anjali / Patel, Ashish

Archiv der Pharmazie

2023 Volume 357, Issue 2, Page(s) e2300420

Abstract: This review article provides an overview of the green synthesis of thiazole derivatives, emphasizing sustainable and environmentally friendly methodologies. Thiazole derivatives possess significant value and find diverse applications across various ... ...

Abstract	This review article provides an overview of the green synthesis of thiazole derivatives, emphasizing sustainable and environmentally friendly methodologies. Thiazole derivatives possess significant value and find diverse applications across various fields. However, conventional synthesis methods often involve hazardous reagents and generate substantial waste, posing environmental concerns. The green synthesis of thiazole derivatives employs renewable starting materials, nontoxic catalysts, and mild reaction conditions to minimize environmental impact. Innovative techniques such as microwave irradiation, ultrasound synthesis, green solvents, a green catalyst-based approach, and mechanochemistry-mediated synthesis are employed, offering advantages in terms of scalability, cost-effectiveness, and purification simplicity. The resulting thiazole derivatives exhibit comparable or enhanced biological activities, showcasing the feasibility and practicality of green synthesis in drug discovery. This review paper underscores the importance of sustainable approaches in functional molecular synthesis and encourages further research in this domain.
MeSH term(s)	Structure-Activity Relationship ; Thiazoles/pharmacology ; Solvents ; Drug Design ; Drug Discovery
Chemical Substances	Thiazoles ; Solvents
Language	English
Publishing date	2023-11-27
Publishing country	Germany
Document type	Journal Article ; Review
ZDB-ID	6381-2
ISSN	1521-4184 ; 0365-6233 ; 1437-1014
ISSN (online)	1521-4184
ISSN	0365-6233 ; 1437-1014
DOI	10.1002/ardp.202300420
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Uf I Zs.4: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Computational Exploration of Naturally Occurring Flavonoids as TGF-β Inhibitors in Breast Cancer: Insights from Docking and Molecular Dynamics Simulations and In-vitro Cytotoxicity Study.

Shah, Umang / Patel, Niyati / Patel, Mehul / Rohit, Shishir / Solanki, Nilay / Patel, Ashish / Patel, Swayamprakash / Patel, Vishwa / Patel, Rajvi / Jawarkar, Rahul D

Chemistry & biodiversity

2024 , Page(s) e202301903

Abstract: Breast cancer is a global health concern, demanding innovative treatments. Targeting the Transforming Growth Factor-beta (TGF-β) signaling pathway, pivotal in breast cancer, is a promising approach. TGF-β inhibits proliferation via G1 phase cell cycle ... ...

Abstract	Breast cancer is a global health concern, demanding innovative treatments. Targeting the Transforming Growth Factor-beta (TGF-β) signaling pathway, pivotal in breast cancer, is a promising approach. TGF-β inhibits proliferation via G1 phase cell cycle arrest, acting as a suppressor initially, but in later stages, it promotes progression by enhancing motility, invasiveness, and metastasis formation. This study explores naturally occurring flavonoids' interactions with TGF-β. Using molecular docking against the protein's crystal structure (PDB Id: 1PY5), Gossypin showed the highest docking score and underwent molecular dynamics simulation, revealing complex flexibility and explaining how flavonoids impede TGF-β signaling in breast cancer. ADMET predictions adhered to Lipinski's rule of Five. Insights into flavonoid-TGF-β binding offer a novel angle for breast cancer treatment. Flavonoids having a good docking score like gossypin, morin, luteolin and taxifolin shown potent cytotoxic effect on breast cancer cell line, MCF-7. Understanding these interactions could inspire flavonoid-based therapies targeting TGF-β to halt breast cancer growth. These findings pave the way for personalized, targeted breast cancer therapies, offering hope against this formidable disease.
Language	English
Publishing date	2024-04-16
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2139001-0
ISSN	1612-1880 ; 1612-1872
ISSN (online)	1612-1880
ISSN	1612-1872
DOI	10.1002/cbdv.202301903
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: A Review and Analysis on Recent Advancements in Bubble Electrospinning Technology for Nanofiber Production.

Patel, Swayamprakash / Patel, Gayatri

Recent patents on nanotechnology

2019 Volume 13, Issue 2, Page(s) 80–91

Abstract: Background: Multiple applications of nanofiber in various segments of science and technology have sparked the interest of innovators to explore the innovative approaches for nanofiber production. The bubble electrospinning technique is the most ... ...

Abstract	Background: Multiple applications of nanofiber in various segments of science and technology have sparked the interest of innovators to explore the innovative approaches for nanofiber production. The bubble electrospinning technique is the most versatile and simplest approach to scale up the production of nanofiber at the industrial level. Numerous patent applications have been filed with innovations and advancements in the field of bubble electrospinning technique. Methods: In present work, different patent applications in the field of bubble electrospinning technique, which represents the advancement in bubble electrospinning technology, are searched and analyzed using various paid and free patent databases. The patent search results are compiled, analyzed and individual innovations are studied in detail to bring all the advancements hitherto in the bubble electrospinning technology under the purview of one review article. Results: The "bubble ws3 electrospin" syntax in the structured search (TAC) facility of the patseer® has revealed most relevant patents on advancement in bubble electrospinning. After applying the family patent filter to the search result (33 patents), ten patents are selected for detailed study. The gist of the invention from each of the patent application or granted patent is recapitulated in this paper, along with their mosaics. Conclusion: Definite number of inventions are available in the field of bubble electrospinning technique. Inventions, which are disclosed, might have their pros and cons with respect to ease of acceptance by the industrial fraternity for large-scale production depending upon simplicity or complexity of the instrument. There is a profound scope of innovation in the bubble electrospinning technology in the areas like bubble stabilization, size and production rate control and much more.
Language	English
Publishing date	2019-03-08
Publishing country	United Arab Emirates
Document type	Journal Article
ISSN	2212-4020
ISSN (online)	2212-4020
DOI	10.2174/1872210513666190306154923
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review.

Kulkarni, Mangesh / Patel, Krishi / Patel, Ayush / Patel, Swayamprakash / Desai, Jagruti / Patel, Mehul / Shah, Umang / Patel, Ashish / Solanki, Nilay

ADMET & DMPK

2023 Volume 12, Issue 1, Page(s) 63–105

Abstract: Background and purpose: The blood-brain barrier (BBB), a critical interface of specialized endothelial cells, plays a pivotal role in regulating molecular and ion transport between the central nervous system (CNS) and systemic circulation.: ... ...

Abstract	Background and purpose: The blood-brain barrier (BBB), a critical interface of specialized endothelial cells, plays a pivotal role in regulating molecular and ion transport between the central nervous system (CNS) and systemic circulation. Experimental approach: This review aims to delve into the intricate architecture and functions of the BBB while addressing challenges associated with delivering therapeutics to the brain. Historical milestones and contemporary insights underscore the BBB's significance in protecting the CNS. Key results: Innovative approaches for enhanced drug transport include intranasal delivery exploiting olfactory and trigeminal pathways, as well as techniques like temporary BBB opening through chemicals, receptors, or focused ultrasound. These avenues hold the potential to reshape conventional drug delivery paradigms and address the limitations posed by the BBB's selectivity. Conclusion: This review underscores the vital role of the BBB in maintaining CNS health and emphasizes the importance of effective drug delivery through this barrier. Nanoparticles emerge as promising candidates to overcome BBB limitations and potentially revolutionize the treatment of CNS disorders. As research progresses, the application of nanomaterials shows immense potential for advancing neurological therapeutics, albeit with careful consideration of safety aspects.
Language	English
Publishing date	2023-10-31
Publishing country	Croatia
Document type	Journal Article ; Review
ISSN	1848-7718
ISSN (online)	1848-7718
DOI	10.5599/admet.2043
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Pharmacological Study of A3 Adenosine Receptor agonist (AB Meca) in Xenograft Lung Cancer Model in Mice through In Silico and In Vivo Approach: Targeting TNF-α.

Solanki, Nilay / Patel, Leena / Shah, Shaini / Patel, Ashish / Patel, Swayamprakash / Patel, Mehul / Shah, Umang

Current drug discovery technologies

2022 Volume 19, Issue 1, Page(s) e140122195498

Abstract: Background: Lung cancer is the leading cause of mortality in India. Adenosine Receptor (AR) has emerged as a novel cancer-specific target. A3AR levels are upregulated in various tumor cells, which may mean that the specific AR may act as a biological ... ...

Abstract	Background: Lung cancer is the leading cause of mortality in India. Adenosine Receptor (AR) has emerged as a novel cancer-specific target. A3AR levels are upregulated in various tumor cells, which may mean that the specific AR may act as a biological marker and target specific ligands leading to cell growth inhibition. Aim: Our aim was to study the efficacy of the adenosine receptor agonist, AB MECA, by in silico (molecular docking) and in vitro (human cancer cells in xenografted mice) studies. Methods: Molecular docking on the AB-meca and TNF-α was performed using AutoDock. A549 Human lung cancer 2 ×10 Results: AB Meca's predicted binding energy (beng) with TNF-α was 97.13 kcal/mol, and the compatible docking result of a small molecular inhibitor with TNF-α native ligand beng was 85.76 kcal/mol. In vivo, a single dose of lung cancer cell A549 is being researched to potentiate tumor development. Doxorubicin and A3AR agonist therapies have lowered TNF-alpha levels that were associated with in silico function. The A3AR Agonist showed myeloprotective effects in the groups treated along with doxorubicin. Conclusion: AB MECA's higher binding energy (beng) with TNF-α mediated reduction of tumor growth in our lung cancer in vivo model suggested that it may be an effective therapy for lung cancer.
MeSH term(s)	Adenosine/analogs & derivatives ; Adenosine A3 Receptor Agonists/pharmacology ; Animals ; Disease Models, Animal ; Doxorubicin ; Heterografts ; Humans ; Lung Neoplasms/drug therapy ; Mice ; Molecular Docking Simulation ; Rats ; Tumor Necrosis Factor-alpha
Chemical Substances	Adenosine A3 Receptor Agonists ; Tumor Necrosis Factor-alpha ; 5'-N-methylcarboxamideadenosine (35788-27-3) ; Doxorubicin (80168379AG) ; Adenosine (K72T3FS567)
Language	English
Publishing date	2022-04-04
Publishing country	United Arab Emirates
Document type	Journal Article
ISSN	1875-6220
ISSN (online)	1875-6220
DOI	10.2174/1570163818666210810142022
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment.

Shah, Umang / Shah, Aneri / Patel, Sandip / Patel, Alkesh / Patel, Mehul / Solanki, Nilay / Patel, Swayamprakash / Patel, Ashish / Patel, Veena / Patel, Bhavesh

CNS & neurological disorders drug targets

2022 Volume 22, Issue 10, Page(s) 1462–1471

Abstract: Over the past 20 years, advances in the field of pathogenesis have inspired researchers to look into novel pharmacological therapeutics that are more focused on the pathophysiological events of the disease (AD). This review article discussed the prior ... ...

Abstract	Over the past 20 years, advances in the field of pathogenesis have inspired researchers to look into novel pharmacological therapeutics that are more focused on the pathophysiological events of the disease (AD). This review article discussed the prior use of statins for the prevention of Alzheimer's disease, which can help prevent the disease. Other drugs, such as memantine and donepezil, are available, but they cannot prevent the onset of AD in middle age. Based on available clinical data, the valuable effects of statins are mediated by alteration of β-amyloid (Aβ) and tau metabolism, genetic and lifestyle risk factors, along with other clinical aspects of AD. These findings suggested that using statins in middle age may help to prevent Alzheimer's disease by modifying genetic and non-genetic risk factors in later stages of life. In the present review, we elaborated upon the modification of risk factors and amyloid metabolism in the development and progression of AD and their modulation through atorvastatin. Future directions in the research and treatment of Alzheimer's disease patients include the use of antisense oligonucleotides (ASO) to change target expression, and researchers discovered decreased markers of oxidative stress in tissues affected by tau pathology in response to RNA interference treatment.
MeSH term(s)	Humans ; Alzheimer Disease/metabolism ; Atorvastatin/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Amyloid beta-Peptides/metabolism ; Cognition ; tau Proteins/metabolism
Chemical Substances	Atorvastatin (A0JWA85V8F) ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Amyloid beta-Peptides ; tau Proteins
Language	English
Publishing date	2022-10-06
Publishing country	United Arab Emirates
Document type	Review ; Journal Article
ZDB-ID	2228394-8
ISSN	1996-3181 ; 1871-5273
ISSN (online)	1996-3181
ISSN	1871-5273
DOI	10.2174/1871527322666221005124808
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5892: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Probiotic Formulations: A Patent Landscaping Using the Text Mining Approach.

Patel, Swayamprakash / Patel, Mruduka S / Patel, Ashish D / Shah, Umang H / Patel, Mehul M / Solanki, Nilay D / Patel, Meet J

Current microbiology

2022 Volume 79, Issue 5, Page(s) 152

Abstract: The outstanding research outcomes and registrations of myriads of probiotic strains have flooded the health market with various innovative probiotic-based products and their patents. The study of patented formulations of probiotics can give an overall ... ...

Abstract	The outstanding research outcomes and registrations of myriads of probiotic strains have flooded the health market with various innovative probiotic-based products and their patents. The study of patented formulations of probiotics can give an overall insight into its existing application. A landscaping review of patents for probiotic-based preparations is presented in the current work. The patent search was performed over commercially available patent databased and analysis tool-PatSeer Pro®. Search strings containing words "Formulation" and "Composition" resulted in more than 3700 patents. Landscaping review of 400 + patents from the last 20 years (2000-2020) was performed using the Text-Mining approach. Text-Mining helped to identify 19 technological clusters which represent these patents. These clusters include the patents of probiotic preparations on animal feed, human food, cosmetics, antimicrobial, antidiabetic, arthritis, etc. A review of this massive number of patents unveiled many exciting preparations. Probiotic-based innovative products for depression, diabetes, Parkinson's, tumor, acne, and animal husbandry are reviewed comprehensively. The present work also unravels a few new-flanged products like probiotic layered condoms, products for acute alcoholism, and traditional Chinese medicine with probiotics. The patent landscape of probiotic-based preparations has presented a whole scenario of probiotic-based preparations. It has also revealed many unexplored areas where innovation can be excelled.
MeSH term(s)	Animals ; Data Mining ; Probiotics
Language	English
Publishing date	2022-04-09
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	134238-1
ISSN	1432-0991 ; 0343-8651
ISSN (online)	1432-0991
ISSN	0343-8651
DOI	10.1007/s00284-022-02836-2
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1446: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito